510(k) Report

510(k) · Cleared

Recalled · 2007

Medtronic Minimed Paradigm Model 512 Insulin Pump and the BD Paradigm Link Glucose Meter

K030531510(k) TraditionalCleared Jun 17, 2003118-day reviewClass II21 CFR 880.5725Recalls 3

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Minimed, Inc. · LZG Pump, Infusion, Insulin

Cleared on Jun 17, 2003 after a 118-day review. The FDA summary names its predicate without a number. 20 later devices descend from it. It has been recalled 3 times.

Decided
Jun 17, 2003
Review
118 days
Class
Class II
Product code
LZG
Recalls
3
Predicates
0

20 later devices descend from it, 2 citing it directly.

Descendants, by year cleared 2004: 1 descendant cleared2008: 3 descendants cleared2009: 1 descendant cleared2012: 3 descendants cleared2013: 1 descendant cleared2015: 1 descendant cleared2016: 2 descendants cleared2019: 1 descendant cleared2021: 2 descendants cleared2022: 1 descendant cleared2023: 1 descendant cleared2024: 2 descendants cleared2026: 1 descendant cleared200020052010201520202025
  1. This deviceK030531 Medtronic Minimed Paradigm Model 512 Insulin Pump and the BD…Minimed, Inc. · 2003
  2. Descendant · cites it directly · 19 of its ownK040603 Paradigm Link Blood Glucose MeterBecton, Dickinson & CO · 2004
  3. Descendant · 2 generations on · 15 of its ownK073231 Onetouch Ultralink Blood Glucose Monitoring SystemLifescan, Inc. · 2008
  4. Descendant · 3 generations on · 13 of its ownK110894 Contour Next Link Wireless Blood Glucose MeterBayer Healthcare · 2012
  5. Descendant · 4 generations on · 10 of its ownK121087 Contour Next Usb Blood Glucose Monitoring SystemBayer Healthcare · 2012
  6. Descendant · 5 generations on · 9 of its ownK150942 Contour Next USB Blood Glucose Monitoring SystemBayer Healthcare · 2015

Showing 5 of 20 descendants. See all descendants

Descendants cleared per year

2004: 12008: 32009: 12012: 32013: 12015: 12016: 22019: 12021: 22022: 12023: 12024: 22026: 1
2004high 3 (2008) · low 0 (2005)2026

Most influential descendants

Showing 5 of 20 · See all
  • K040603Paradigm Link Blood Glucose MeterBecton, Dickinson & CO · 2004 · cites it directly19descendants
  • K073231Onetouch Ultralink Blood Glucose Monitoring SystemLifescan, Inc. · 2008 · 2 generations on15descendants
  • K110894Contour Next Link Wireless Blood Glucose MeterBayer Healthcare · 2012 · 3 generations on13descendants
  • K121087Contour Next Usb Blood Glucose Monitoring SystemBayer Healthcare · 2012 · 4 generations on10descendants
  • K150942Contour Next USB Blood Glucose Monitoring SystemBayer Healthcare · 2015 · 5 generations on9descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K030531Medtronic Minimed Paradigm Model 512 Insulin Pump and the BD Paradigm Link…Minimed, Inc.2003—
+1K040603Paradigm Link Blood Glucose MeterBecton, Dickinson & CO2004—
+2K073231Onetouch Ultralink Blood Glucose Monitoring SystemLifescan, Inc.2008—
+3K110894Contour Next Link Wireless Blood Glucose MeterBayer Healthcare2012—
+4K121087Contour Next Usb Blood Glucose Monitoring SystemBayer Healthcare2012—
+5K150942Contour Next USB Blood Glucose Monitoring SystemBayer Healthcare2015—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200410
200830
200910
201230
201310
201510
201620
201910
202120
202210
202310
202420
202610
FIG. 1 — Lineage of K030531, 2003–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LZG? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LZG device

  1. #1 K253534 Pivot Insulin Delivery Systemscore 16.8 · 10 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (3)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*—Medtronic MiniMed Paradigm Model 511 Insulin Pump
Named without a submission number
—
*—BD Logic Glucose Monitor
Named without a submission number
—
*—Medtronic MiniMed Model 7304 ComLink
Named without a submission number
—

What descends from it? (20)

See all 20

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K040603Paradigm Link Blood Glucose MeterBecton, Dickinson & CO200419
K080639Symphony Glucose Management SystemAnimas Corp.20082

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Apr 27, 2007Not classifiedZ-1007-2007OtherExposure to Magnetic Resonance Imaging (MRI) has resulted in damage to the component that monitors and controls movement of the motor in the MiniMed Paradigm insulin infusion pump. Although there were alarms as a result of the damage…
Sep 14, 2004Not classifiedZ-0010-05OtherSeveral complaints of pumps exhibiting A47 alarms were received. Investigation revealed the alarms occurred when the pump attempted to display text that exceeded the maximum display length of the pump screen. The investigation revealed…
Jan 29, 2004Not classifiedZ-0763-04Other39 lots of BD Test strip may produce an increased frequency of E-3 messages when used during blood glucose testing.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K040603 (Becton, Dickinson & CO, 2004) has gone furthest, with 19 descendants of its own.

How does its category compare?

All LZG devices

LZG Pump, Infusion, Insulin: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · LZG

2in 2024

2007: 32008: 62009: 22010: 22011: 42012: 32013: 22014: 42015: 12016: 42017: 12018: 12019: 22021: 12022: 12023: 12024: 22026 (partial year): 2
2007high 6 (2008) · low 0 (2020)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LZG

116in 2016

2007: 112 days median2008: 129 days median2011: 189 days median2012: 73 days median2014: 123 days median2016: 116 days median
2007high 189 (2011) · low 73 (2012)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LZG

1in 2022

2007: 12008: 132009: 22010: 42011: 22012: 42013: 3, 1 Class I2014: 2, 1 Class I2015: 2, 2 Class I2018: 3, 2 Class I2019: 52022: 1, 1 Class I2026 (partial year): 2, 2 Class I
2007high 13 (2008) · low 0 (2016)2026

Class I (9 since 2007) Class II/III not classified

Adverse event reports per year · LZG

12,004in 2025

2007: 5,1102008: 5,7112009: 9,4712010: 10,1752011: 12,8582012: 18,3672013: 30,0592014: 49,1882015: 69,1362016: 56,5812017: 44,4722018: 32,6522019: 29,0272020: 32,5882021: 31,5222022: 28,2252023: 21,9722024: 18,2282025: 12,004
2007high 69,136 (2015) · low 5,110 (2007)2025

MAUDE reports naming product code LZG, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007311215,110
20086129135,711
20092—29,471
20102—410,175
20114189212,858
2012373418,367
20132—3 (1)30,059
201441232 (1)49,188
20151—2 (2)69,136
20164116056,581
20171—044,472
20181—3 (2)32,652
20192—529,027
20200—032,588
20211—031,522
20221—1 (1)28,225
20231—021,972
20242—018,228
20250—012,004
20262—2 (2)—

What is it indicated for?

The Medtronic MiniMed Paradigm Model 512 Insulin Pump is indicated for the continuous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in persons requiring insulin. The BD Paradigm Link Blood Glucose Monitor is intended to be used for the quantitative measurement of glucose in whole blood. It is intended for use by people with diabetes mellitus in the home as an aid to monitor the effectiveness of diabetes control.…

Read the full statement (216 words)

The Medtronic MiniMed Paradigm Model 512 Insulin Pump is indicated for the continuous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in persons requiring insulin.

The BD Paradigm Link Blood Glucose Monitor is intended to be used for the quantitative measurement of glucose in whole blood. It is intended for use by people with diabetes mellitus in the home as an aid to monitor the effectiveness of diabetes control. It is not intended for use in the diagnosis of or screening for diabetes mellitus and is not intended for use on neonates.

The BD Paradigm Link Blood Glucose Monitor is specifically indicated for the quantitative measurement of glucose in whole blood samples obtained from the fingertip.

When used together, the BD Paradigm Link Glucose Monitor can automatically telemeter glucose values to the Model 512 Insulin Pump using radio frequency communication. The glucose value received by the Model 512 Insulin Pump is used as the default glucose value by the pump’s Bolus Wizard feature if the Bolus Wizard is used within 12 minutes of the glucose value transmission.

The BD Link Glucose Monitor can also serve as p radio frequency interface to allow communication between the Model 512 Insulin Pump and a personal computer running the appropriate Medtronic MiniMed communications software.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K030531: Medtronic Minimed Paradigm Model 512 Insulin Pump and the BD Paradigm Link Glucose Meter.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K030531

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026